| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.9M | +16.7% |
| Cost of Revenue | $17.0M | +4.2% |
| Gross Profit | $29.9M | +25.2% |
| R&D Expense | $676K | +6.3% |
| SG&A Expense | $9.5M | +1.3% |
| Operating Income | $8.1M | +189.2% |
| Pre-tax Income | $7.0M | +515.6% |
| Income Tax | $4K | -76.5% |
| Net Income | $6.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -58.2% |
| Accounts Receivable | $8.5M | +71.5% |
| Inventory | $1.2M | -1.3% |
| Current Assets | $11.8M | +14.1% |
| Total Assets | $14.8M | +13.6% |
| Current Liabilities | $10.6M | -39.3% |
| Total Liabilities | $17.0M | -39.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.6M | +22.6% |
| Capital Expenditures | $876K | +86.4% |
| Investing Cash Flow | -$876K | -906.9% |
| Financing Cash Flow | -$5.8M | -15.4% |
| Free Cash Flow | $3.8M | +13.6% |
| +735.7% |
| EPS (Basic) | $1.42 | +647.4% |
| EPS (Diluted) | $0.40 | +122.2% |
| Stockholders' Equity |
| -$2.2M |
| +96.4% |